Galmed Pharmaceuticals logo

Galmed Pharmaceuticals share price today

(GLMD)

Galmed Pharmaceuticals share price is $3.05 & ₹259.18 as on 21 Dec 2024, 2.30 'hrs' IST

$3.05

-0.02

(-0.65%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Galmed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Galmed Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Galmed Pharmaceuticals. Get details on the Indian mutual funds that are investing in Galmed Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Galmed Pharmaceuticals's financials.

Galmed Pharmaceuticals share price movements

  • Today's Low: $2.89
    Today's High: $3.27

    Day's Volatility :11.62%

  • 52 Weeks Low: $2.56
    52 Weeks High: $23.80

    52 Weeks Volatility :89.24%

Galmed Pharmaceuticals Returns

PeriodGalmed Pharmaceuticals LtdIndex (Russel 2000)
3 Months
-67.38%
0.0%
6 Months
-18.14%
0.0%
1 Year
-39.06%
0.0%
3 Years
-99.17%
-19.7%

Galmed Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$3.07
Open
$3.28
Today's High
$3.27
Today's Low
$2.89
Market Capitalization
$5.1M
Today's Volume
$72.1K
52 Week High
$23.8
52 Week Low
$2.56
Revenue TTM
$0.0
EBITDA
$-6.1M
Earnings Per Share (EPS)
$69.72
PE Ratio
0.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-52.67%

How to invest in Galmed Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Galmed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galmed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galmed Pharmaceuticals or GLMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galmed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galmed Pharmaceuticals shares which would translate to 0.279 fractional shares of Galmed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Galmed Pharmaceuticals, in just a few clicks!

Returns in Galmed Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Galmed Pharmaceuticals investment value today

Current value as on today

₹1,41,318

Returns

₹41,318

(+41.32%)

Returns from Galmed Pharmaceuticals Stock

₹39,122 (false-39.12%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Galmed Pharmaceuticals

-48%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Galmed Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -48% less investors are searching Galmed Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Galmed Pharmaceuticals

  • UBS Group AG

    0.32%

  • CVI Holdings LLC

    0.24%

  • Tower Research Capital LLC

    0.01%

  • Morgan Stanley - Brokerage Accounts

    0.01%

Analyst Recommendation on Galmed Pharmaceuticals

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Galmed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Galmed Pharmaceuticals

What analysts predicted

Upside of 293.44%

Current:

$3.05

Target:

$12.00

Insights on Galmed Pharmaceuticals

  • Price Movement

    In the last 3 months, GLMD stock has moved down by -67.4%
  • GLMD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 66.1%
  • GLMD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 122.2%

Galmed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Galmed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Galmed Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Galmed Pharmaceuticals Ltd
8.93%
-18.14%
-39.06%
-99.17%
-99.71%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Galmed Pharmaceuticals Ltd
0.04
0.04
0.0
0.0
-0.53
-0.29
NA
33.01
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Galmed Pharmaceuticals Ltd
Buy
$5.1M
-99.71%
0.04
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Galmed Pharmaceuticals

galmed pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of aramchol, a novel, once-daily, oral therapy for treating liver diseases utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or fabacs. aramchol is initially being developed for treating non-alcoholic steato-hepatitis, or nash, a chronic disease affecting a large population, for treating patients who also suffer from obesity and insulin resistance. galmed pharmaceuticals galmed’s business has been, in its current legal structure, was incorporated in israel on july 31, 2013 as a privately held company. however, operating since 2000 under a different group of companies established in the same year. galmed was co-founded by professor tuvia gilat and allen baharaff, based on professor gilat’s extensive research in fabac’s and nash.
Organization
Galmed Pharmaceuticals
Employees
3
CEO
Mr. Allen Baharaff
Industry
Health Technology

Management People of Galmed Pharmaceuticals

NameTitle
Mr. Allen Baharaff
Co-Founder, President, CEO & Chairman
Mr. Doron Cohen
Chief Financial Officer
Mr. Guy Nehemya
COO & Data Protection Officer
Mr. Yohai Stenzler CPA
Chief Accounting Officer
Dr. Liat Hayardeny MBA, Ph.D.
Chief Scientific Officer
Dr. Tali Gorfine
Medical Consultant

Important FAQs about investing in Galmed Pharmaceuticals from India :

What is Galmed Pharmaceuticals share price today?

Galmed Pharmaceuticals share price today stands at $3.05, Open: $3.28 ; Previous Close: $3.07 ; High: $3.27 ; Low: $2.89 ; 52 Week High: $23.80 ; 52 Week Low: $2.56. The stock opens at $3.28, after a previous close of $3.07. The stock reached a daily high of $3.27 and a low of $2.89, with a 52-week high of $23.80 and a 52-week low of $2.56.

Can Indians buy Galmed Pharmaceuticals shares?

Yes, Indians can invest in the Galmed Pharmaceuticals (GLMD) from India.

With INDmoney, you can buy Galmed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Galmed Pharmaceuticals at zero transaction cost.

How can I buy Galmed Pharmaceuticals shares from India?

It is very easy to buy Galmed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galmed Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Galmed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Galmed Pharmaceuticals stocks?

To start investing in Galmed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Galmed Pharmaceuticals

Today’s highest price of Galmed Pharmaceuticals (GLMD) is $3.27.

Today’s lowest price of Galmed Pharmaceuticals (GLMD) is $2.89.

What is today's market capitalisation of Galmed Pharmaceuticals

Today's market capitalisation of Galmed Pharmaceuticals GLMD is 5.1M

What is the 52 Week High and Low Range of Galmed Pharmaceuticals

  • 52 Week High

    $23.80

  • 52 Week Low

    $2.56

What are the historical returns of Galmed Pharmaceuticals?

  • 1 Month Returns

    8.93%

  • 3 Months Returns

    -18.14%

  • 1 Year Returns

    -39.06%

  • 5 Years Returns

    -99.71%

Who is the Chief Executive Officer (CEO) of Galmed Pharmaceuticals

Mr. Allen Baharaff is the current Chief Executive Officer (CEO) of Galmed Pharmaceuticals.